Lunsumio subkutan 45 mg/1ml, Injektionslösung

7680702210025 CH-70221 Injektionslösung

Associated product:

Lunsumio subkutan 45 mg/1ml, Injektionslösung

No image available

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
mosunetuzumabum
45.0 MG Substance Wirkstoff (Principe actif)
histidinum
- Substance HNIDK
acidum aceticum glaciale
- Substance HNIDK
saccharum
- Substance HNIDK
methioninum
- Substance HNIDK
polysorbatum 20
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK

Authorization holder

Roche Pharma (Schweiz) AG

4058 Basel

Authorization information

Swissmedic authorization number
70221
Drug name
Lunsumio subkutan, Injektionslöung
Galenic form
LSINJ
ATC Code
L01FX25
Authorization status
B
Dispensing category
A
First authorization
03/07/2026
Authorization expiration date
09/02/2027
IT Number
07.16.1.
Domain
Human medicine
Field of application
follikuläres Lymphom

Package details

Description (FR)
LUNSUMIO s.c. 45 mg/1 ml sol inj 45 mg 1 pce
Description (DE)
LUNSUMIO s.c. 45 mg/1 ml Inj Lös 45 mg 1 Stk
Market launch
03/07/2026
Market withdrawal
03/07/2026
Narcotic (BTM)
No

Other package sizes (1)

LUNSUMIO s.c. 5 mg/0.5 ml sol inj 5 mg 1 pce
1 DUR
GTIN: 7680702210018
View
Buy us a coffee Explore the data